Advertisement
AFIB Forex Haberleri
Acutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFO
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday that it expects revenues for the fourth quarter in a range of approximately $4.7 million to $4.9 million, compared to $4.4 million in the prior-year quarter.
RTTNews
|
843 gün önce
Acutus Medical Announces FDA Cleared Commercial Launch Of AcQCross Qx System
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday the commercial launch of an expanded suite of left-heart access products to now include the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device.
RTTNews
|
1039 gün önce
